LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $18,275,000 | +11.1% | 133,460 | +10.5% | 0.38% | +7.0% |
| Q3 2017 | $16,450,000 | -0.8% | 120,820 | -11.6% | 0.36% | +1.1% |
| Q2 2017 | $16,586,000 | +26.4% | 136,620 | +10.2% | 0.35% | +24.4% |
| Q1 2017 | $13,123,000 | +59.3% | 123,985 | +53.0% | 0.28% | +52.2% |
| Q4 2016 | $8,236,000 | +21.7% | 81,055 | +22.3% | 0.19% | +44.2% |
| Q3 2016 | $6,765,000 | -14.4% | 66,285 | 0.0% | 0.13% | -17.8% |
| Q2 2016 | $7,906,000 | +17.1% | 66,285 | +5.1% | 0.16% | +17.2% |
| Q1 2016 | $6,753,000 | -1.4% | 63,055 | -0.2% | 0.13% | +2.3% |
| Q4 2015 | $6,851,000 | +31.4% | 63,190 | +3.8% | 0.13% | +23.6% |
| Q3 2015 | $5,215,000 | -5.5% | 60,890 | +11.4% | 0.11% | +7.1% |
| Q2 2015 | $5,516,000 | – | 54,670 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |